- Home
- DNLI vs ALVO Comparison
DNLI vs ALVO Comparison
Compare DNLI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ALVO
- Stock Information
- Founded
- DNLI 2013
- ALVO 2013
- Country
- DNLI United States
- ALVO Luxembourg
- Employees
- DNLI N/A
- ALVO N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- DNLI Health Care
- ALVO Health Care
- Exchange
- DNLI Nasdaq
- ALVO Nasdaq
- Market Cap
- DNLI 2.1B
- ALVO 2.5B
- IPO Year
- DNLI 2017
- ALVO N/A
- Fundamental
- Price
- DNLI $15.43
- ALVO $8.33
- Analyst Decision
- DNLI Strong Buy
- ALVO
- Analyst Count
- DNLI 15
- ALVO 0
- Target Price
- DNLI $33.62
- ALVO N/A
- AVG Volume (30 Days)
- DNLI 2.0M
- ALVO 486.2K
- Earning Date
- DNLI 11-05-2025
- ALVO 08-13-2025
- Dividend Yield
- DNLI N/A
- ALVO N/A
- EPS Growth
- DNLI N/A
- ALVO N/A
- EPS
- DNLI N/A
- ALVO 0.22
- Revenue
- DNLI N/A
- ALVO $562,478,000.00
- Revenue This Year
- DNLI N/A
- ALVO $33.32
- Revenue Next Year
- DNLI $802.87
- ALVO $46.16
- P/E Ratio
- DNLI N/A
- ALVO $37.86
- Revenue Growth
- DNLI N/A
- ALVO 82.19
- 52 Week Low
- DNLI $10.57
- ALVO $7.35
- 52 Week High
- DNLI $33.33
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- DNLI 56.61
- ALVO 48.09
- Support Level
- DNLI $14.52
- ALVO $7.85
- Resistance Level
- DNLI $16.20
- ALVO $8.12
- Average True Range (ATR)
- DNLI 0.70
- ALVO 0.27
- MACD
- DNLI -0.01
- ALVO 0.01
- Stochastic Oscillator
- DNLI 62.44
- ALVO 39.47
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.